Busyamas Chewaskulyong

8PUBLICATIONS
26CO-AUTHORS
Cancer diagnosisMedical infection agents (incl. prions)Predictive and prognostic markersFood properties (incl. characteristics and health benefits)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 28, 2026
The Impact of the COVID-19 Pandemic on Diagnosis, Treatment, and Survival of Lung Cancer Patients in Thailand from 2019-2021.

Chaiyut Charoentum, Chawin Aksorn, Khemruthai Chaiwipassatorn

|Jan 28, 2026
Differential Circulating miRNA Responses to PM Exposure in Healthy and Diabetes Mellitus Patients: Implications for Lung Cancer Susceptibility.

Moe Thi Thi Han, Nichakorn Satitpornbunpot, Naoomi Tominaga

|Nov 07, 2024
Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients.

Busyamas Chewaskulyong, Pattarapong Satjaritanun, Thanika Ketpueak

|Sep 14, 2024
The Impact of a Multidisciplinary Team Conference on Non-Small Cell Lung Cancer Care: Time Barriers and Long-Term Outcomes.

Somcharoen Saeteng, Busyamas Chewaskulyong, Chaiyut Charoentum

|Sep 14, 2024
Dietary Counseling Outcomes in Patients with Lung Cancer in an Upper-Middle-Income Country: An Open-Label Randomized Controlled Trial.

Busyamas Chewaskulyong, Haritchanan Malairungsakul, Supawan Buranapin

|Jul 20, 2024
Comparison of treatment outcome between first-line combination immunotherapy (anti-PD-L1 or anti-PD1) with or without chemotherapy and chemotherapy alone in advanced non-small cell lung cancer patients in tertiary care hospital.

Danainut Naratornsirakul, Busyamas Chewaskulyong, Sarawut Kongkarnka

Pageof 2

Frequent Collaborators

4 joint publications

Thatthan Suksombooncharoen

3 joint publications

Apichat Tantraworasin

3 joint publications

Chaiyut Charoentum

1 joint publications

Naoomi Tominaga